Description: Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives.
sustainability (3792) access (2065) biosimilars (83) generics (79) sandoz (74)
Media Release Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines
Media Release Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation
Media Release Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation